We are live on
!
Find out more
VIA
Vident Investment Advisory Portfolio holdings
AUM
$2.9B
1-Year Est. Return
24.67%
This Fund
S&P 500
This Quarter
Est. Return
-2.21%
1 Year Est. Return
+24.67%
3 Year Est. Return
+82.63%
5 Year Est. Return
+113.33%
10 Year Est. Return
–
AUM
$1.14B
AUM Growth
-$97.7M
(-7.9%)
Cap. Flow
-$62.6M
Cap. Flow
% of AUM
-5.46%
Top 10 Holdings %
Top 10 Hldgs %
17%
Holding
468
New
33
Increased
200
Reduced
215
Closed
20
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VCRA
VOCERA COMMUNICATIONS, INC.
VCRA
|
+$19.6M |
| 2 |
ServiceNow
NOW
|
+$12.3M |
| 3 |
IRBT
iRobot
IRBT
|
+$6.22M |
| 4 |
HOLI
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
|
+$3.44M |
| 5 |
PTC
PTC
|
+$2.42M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$43.5M |
| 2 |
Oceaneering
OII
|
+$24.7M |
| 3 |
Ambarella
AMBA
|
+$7.15M |
| 4 |
NVIDIA
NVDA
|
+$5.26M |
| 5 |
MTLS
Materialise
MTLS
|
+$4.49M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.08% |
| 2 | Healthcare | 15.03% |
| 3 | Industrials | 9.87% |
| 4 | Consumer Discretionary | 5.65% |
| 5 | Consumer Staples | 3.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
YMAB
101
DELISTED
Y-mAbs Therapeutics
YMAB
| $1.68M | 0.15% |
64,571
-1,845
| -3% | -$47.1K |
|
102
UnitedHealth
UNH
$370B
| $1.68M | 0.15% |
7,729
+337
| +5% | +$81.3K |
|
103
IBM
IBM
$224B
| $1.61M | 0.14% |
11,567
-255
| -2% | -$34.4K |
|
104
AstraZeneca
AZN
$250B
| $1.59M | 0.14% |
17,857
-358
| -2% | -$31K |
|
105
MarketAxess Holdings
MKTX
$5.72B
| $1.58M | 0.14% |
4,833
-333
| -6% | -$119K |
|
106
Lamb Weston
LW
$7.19B
| $1.57M | 0.14% |
21,622
+3,929
| +22% | +$270K |
|
|
MOR
107
DELISTED
MorphoSys AG American Depositary Shares
MOR
| $1.56M | 0.14% |
56,690
-1,620
| -3% | -$46.4K |
|
108
Clorox
CLX
$12.7B
| $1.55M | 0.14% |
10,220
+81
| +0.8% | +$12.8K |
|
109
CVS Health
CVS
$122B
| $1.54M | 0.14% |
24,491
+12,066
| +97% | +$715K |
|
110
Kraft Heinz
KHC
$30B
| $1.53M | 0.13% |
54,801
+18,651
| +52% | +$537K |
|
111
Campbell Soup
CPB
$6.87B
| $1.51M | 0.13% |
32,275
-90
| -0.3% | -$3.89K |
|
112
Healthpeak Properties
DOC
$14.8B
| $1.51M | 0.13% |
42,365
+2,151
| +5% | +$72.6K |
|
113
Coca-Cola
KO
$375B
| $1.5M | 0.13% |
27,548
-10,384
| -27% | -$556K |
|
114
Hershey
HSY
$36.6B
| $1.48M | 0.13% |
9,561
+742
| +8% | +$112K |
|
115
Xencor
XNCR
$1.55B
| $1.47M | 0.13% |
43,490
-1,243
| -3% | -$49.6K |
|
116
Public Storage
PSA
$61.3B
| $1.46M | 0.13% |
5,949
+324
| +6% | +$81.4K |
|
117
Biogen
BIIB
$30.7B
| $1.46M | 0.13% |
6,256
+1,554
| +33% | +$362K |
|
118
Chevron
CVX
$366B
| $1.46M | 0.13% |
12,276
+652
| +6% | +$79.2K |
|
119
Allogene Therapeutics
ALLO
$694M
| $1.44M | 0.13% |
52,823
-1,509
| -3% | -$43K |
|
120
CenterPoint Energy
CNP
$26.8B
| $1.42M | 0.12% |
46,913
+3,777
| +9% | +$109K |
|
121
Marathon Petroleum
MPC
$83.7B
| $1.39M | 0.12% |
22,930
+13,619
| +146% | +$718K |
|
122
Moderna
MRNA
$23.6B
| $1.39M | 0.12% |
87,410
-2,497
| -3% | -$36.9K |
|
123
Amgen
AMGN
$222B
| $1.39M | 0.12% |
7,156
+1,683
| +31% | +$323K |
|
124
McDonald's
MCD
$195B
| $1.39M | 0.12% |
6,450
-103
| -2% | -$22.1K |
|
125
Lumen
LUMN
$6.44B
| $1.38M | 0.12% |
110,848
+30,831
| +39% | +$366K |
|
Similar funds
EST
TCM
AWS
WI
JP
VCM
FCB
FCFS
Vident Investment Advisory's Q3 2019 Portfolio in Review
As of Q3 2019, Vident Investment Advisory held 468 positions worth $1.14B, down 7.9% from $1.24B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Vident Investment Advisory withdrew a net $62.6M in Q3 2019, closing 20 positions and reducing 215 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $43.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Vident Investment Advisory opened a new position in VOCERA COMMUNICATIONS, INC. worth $18.6M.
- Vident Investment Advisory's largest Q3 2019 buy was VOCERA COMMUNICATIONS, INC.: 756,459 shares worth $18.6M.
- Vident Investment Advisory added most to iRobot in Q3 2019, an estimated $6.22M increase.
- Vident Investment Advisory's biggest Q3 2019 reduction was Ambarella, cutting an estimated $7.15M.
- Vident Investment Advisory fully exited State Street SPDR S&P 500 ETF Trust in Q3 2019, selling an estimated $43.5M.
- Vident Investment Advisory's ten largest holdings make up 17% of its $1.14B portfolio in Q3 2019.
- Vident Investment Advisory opened 33 new positions and closed 20 in Q3 2019.
- Vident Investment Advisory's portfolio value fell 7.9% quarter-over-quarter to $1.14B.
Based on Vident Investment Advisory's 13F filing for Q3 2019, filed 13 Nov 2019.